Amid Changing Policies and Funding Instability, the Future of mRNA Vaccine Research in the US is at Risk The United States, once hailed as the global frontrunner in messenger RNA (mRNA) vaccine technology, is now confronting a precarious future as shifts in government policies, regulatory turmoil, and decreasing funding endanger the ongoing development and dominance […]
Read More